Etiology and treatment approaches for trichomoniasis
The disease is caused by the microorganism Trichomonas vaginalis. The main goal of pharmacotherapy is the complete eradication of the pathogen from the patient's body.
To combat the infection, the baseline group of nitroimidazoles is used, which includes such well-known drugs as:
- Metronidazole (also known as Trichopol)
- Ornidazole (Tiberal / Gairo)
- Tinidazole
The dosage forms of these medications allow them to be used both systemically in the form of tablets and topically using vaginal suppositories. As an alternative therapy option, nitrofurans, specifically furazolidone, can be prescribed.
Features of giardiasis therapy
The pathogenesis of giardiasis is associated with the localization of parasites in the upper sections of the intestine, as well as in the bile ducts and the gallbladder itself. The reproduction of pathogens in these areas often leads to a clinical consequence in the form of cholecystitis development.
The arsenal of antiprotozoal agents for this pathology includes:
- Nitroimidazoles (metronidazole, tinidazole).
- Specific agents — Aminoquinol and Emetine hydrochloride.
The choice of a specific drug depends on the clinical picture and the features of the pathological process course.
Classification of main drugs
Pharmacological agents used for these protozoal infections are divided into several categories. Within the classification of the main group of antiprotozoal agents, nitroimidazoles are distinguished, which are contrasted with other pharmacological classes (such as macrolides, tetracyclines, and fluoroquinolones). In practice, nitroimidazoles form the basis of therapeutic regimens for both trichomoniasis and giardiasis.
Briefly: answers to topical questions
What is the mechanism of the antiprotozoal action of nitroimidazoles?
The mechanism of the antiprotozoal action of nitroimidazoles consists in the intracellular bioactivation of the drug followed by damage to the parasite's structures. Metronidazole is a prodrug that is activated by the reduction of the nitro group under conditions of a high negative redox potential characteristic of protozoa. The reduced forms of the drug exert a pronounced cytotoxic effect:
- Binding to macromolecules — they interact with the proteins and membranes of the parasite.
- Damage to the genetic apparatus — they cause inhibition of DNA replication processes, which leads to severe cell damage and death.
What are the main adverse effects characteristic of metronidazole?
The main adverse effects of metronidazole include disorders of the gastrointestinal tract, the nervous system, and allergic reactions. Characteristic adverse events include:
- Dyspeptic disorders — GI tract dysfunctions.
- Taste alteration — appearance of a metallic bitter taste in the mouth.
- Neurological reactions — specific disorders of the nervous system.
- Allergic reactions — hypersensitivity reactions.
- Disulfiram-like effect — delay in the oxidation of ethanol at the acetaldehyde stage due to the inhibition of acetaldehyde dehydrogenase, which causes intoxication when alcohol is consumed.
What are the contraindications to the use of nitroimidazoles?
Contraindications and limitations to the use of nitroimidazoles depend on the specific drug and clinical situation.
- Ornidazole in the treatment of giardiasis is contraindicated in children under 3 years of age and children with a body weight of less than 20 kg.
- Metronidazole, ornidazole, and tinidazole during pregnancy can be used no earlier than the 2nd trimester.
What is the dosing regimen of metronidazole in the treatment of trichomoniasis?
The dosing regimen of metronidazole in the treatment of urogenital trichomoniasis:
- In adults with lower urogenital tract involvement: metronidazole 2.0 g orally, once.
- In pregnant women: metronidazole 2.0 g orally, once; the use of metronidazole is possible no earlier than the 2nd trimester of pregnancy.
- Alternative regimen in pregnant women according to global data: metronidazole 500 mg twice daily for 7 days.
- In pregnant women, concurrently with oral medications, the use of imidazole derivatives intravaginally is possible.
Nitro-fighters (nitroimidazoles and nitrofurans) clear the intestines and urogenital tract of protozoan parasites.
Class and exam questions
Which group of drugs is the main one for the treatment of trichomoniasis?
The main group of drugs is nitroimidazoles, which include metronidazole, ornidazole, and tinidazole.
What dosage forms are used for the treatment of trichomoniasis?
The drugs are used both systemically in the form of tablets and topically in the form of vaginal suppositories.
What GI complication is characteristic of giardiasis?
Due to the localization of Giardia in the bile ducts and gallbladder, the clinical consequence is often the development of cholecystitis.
What else to study on this topic
- Mechanisms of protozoan resistance to nitroimidazoles
- Pharmacokinetics and routes of administration of metronidazole and ornidazole
- Features of the use of furazolidone in alternative regimens
- Pharmacological properties of specific agents: Aminoquinol and Emetine hydrochloride
- Prevention and treatment of concomitant inflammatory processes in giardiasis
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on the topic "Drugs for the treatment of trichomoniasis and giardiasis" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Drugs for protozoan infections" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.